Alzchem Group Ag Stock Earnings Per Share
ACT Stock | EUR 57.40 0.20 0.35% |
AlzChem Group AG fundamentals help investors to digest information that contributes to AlzChem Group's financial success or failures. It also enables traders to predict the movement of AlzChem Stock. The fundamental analysis module provides a way to measure AlzChem Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzChem Group stock.
AlzChem |
AlzChem Group AG Company Earnings Per Share Analysis
AlzChem Group's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
According to the company disclosure, AlzChem Group AG has an Earnings Per Share of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Earnings Per Share (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
AlzChem Fundamentals
Current Valuation | 261.71 M | |||
Price To Book | 1.35 X | |||
Price To Sales | 0.37 X | |||
Revenue | 422.29 M | |||
EBITDA | 62.69 M | |||
Net Income | 27.59 M | |||
Total Debt | 37.55 M | |||
Cash Flow From Operations | 43.02 M | |||
Market Capitalization | 249.32 M | |||
Total Asset | 377.67 M | |||
Z Score | 4.6 | |||
Annual Yield | 0.03 % | |||
Net Asset | 377.67 M | |||
Last Dividend Paid | 0.75 |
About AlzChem Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzChem Group AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzChem Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzChem Group AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.